We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -15.00 | -0.91% | 1,636.00 | 1,638.00 | 1,639.00 | 1,661.50 | 1,635.50 | 1,656.50 | 4,329,161 | 16:35:12 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.69 | 67.46B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 4500C
GlaxoSmithKline PLC
19 January 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
Hot Features
Premium
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===========================================================
a) Name Mr N Hirons
=== ====================== ===================================
b) Position/status SVP, Global Ethics & Compliance
=== ====================== ===================================
c) Initial notification/ Initial notification
amendment
=== ====================== ===================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===========================================================
a) Name GlaxoSmithKline plc
=== ====================== ===================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ===================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===========================================================
a) Description GlaxoSmithKline plc American
of the financial Depositary Shares ('ADSs')
instrument ISIN: US37733W1053
=== ====================== ===================================
b) Nature of Acquisition of ADSs following
the transaction the re-investment of dividends
paid to shareholders on 11 January
2018.
=== ====================== ===================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$38.0676 19.625
--------- ----------
=== ====================== ===================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ===================================
e) Date of the 2018-01-18
transaction
=== ====================== ===================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ====================== ===================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===========================================================
a) Name Mr B McNamara
=== ====================== ===================================
b) Position/status CEO, Consumer Healthcare
=== ====================== ===================================
c) Initial notification/ Initial notification
amendment
=== ====================== ===================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===========================================================
a) Name GlaxoSmithKline plc
=== ====================== ===================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ===================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===========================================================
a) Description American Depositary Shares ('ADSs')
of the financial ISIN: US37733W1053
instrument
=== ====================== ===================================
b) Nature of Acquisition of ADSs following
the transaction the re-investment of dividends
paid to shareholders on 11 January
2018.
=== ====================== ===================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$38.0676 232.515
--------- ----------
=== ====================== ===================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ===================================
e) Date of the 2018-01-18
transaction
=== ====================== ===================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ====================== ===================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===========================================================
a) Name Mr D E Troy
=== ====================== ===================================
b) Position/status SVP & General Counsel
=== ====================== ===================================
c) Initial notification/ Initial notification
amendment
=== ====================== ===================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===========================================================
a) Name GlaxoSmithKline plc
=== ====================== ===================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ===================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===========================================================
a) Description American Depositary Shares ('ADSs')
of the financial ISIN: US37733W1053
instrument
=== ====================== ===================================
b) Nature of Acquisition of ADSs following
the transaction the re-investment of dividends
paid to shareholders on 11 January
2018.
=== ====================== ===================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$38.0676 1826.446
--------- ----------
=== ====================== ===================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ===================================
e) Date of the 2018-01-18
transaction
=== ====================== ===================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ====================== ===================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDKLFFVFFFBBZ
(END) Dow Jones Newswires
January 19, 2018 12:17 ET (17:17 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
